Ocugen is trading 6.1% down at $0.92 on October 9, 2026, with no specific company catalyst identified for the decline. - Company news shows a scientific-conference presentation scheduled for later on October 9; no results announcement is reported. - A shareholder meeting on an authorized-share proposal was adjourned to October 26, but the available report does not link it to Friday’s move. - The supplied sector context is positive and does not explain the drop.